These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ORA's role at FDA headquarters and in the field for product recalls. Whetstone SN Food Drug Law J; 1998; 53(3):513-6. PubMed ID: 10346723 [No Abstract] [Full Text] [Related]
3. The trouble with recalls. Consum Rep; 2004 Aug; 69(8):12-7. PubMed ID: 15243992 [No Abstract] [Full Text] [Related]
4. Reporting to the FDA. Dippel JV RN; 1993 Dec; 56(12):61-2. PubMed ID: 8265993 [No Abstract] [Full Text] [Related]
5. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework? Basile EM; Lorell BH Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031 [No Abstract] [Full Text] [Related]
6. FDA works to reduce preventable medical device injuries. Rados C FDA Consum; 2003; 37(4):29-33. PubMed ID: 12971346 [No Abstract] [Full Text] [Related]
7. Medical device recalls from 2004 to 2006: a focus on Class I recalls. Villarraga ML; Guerin HL; Lam T Food Drug Law J; 2007; 62(3):581-92. PubMed ID: 17915400 [No Abstract] [Full Text] [Related]
8. Complying with US and European complaint handling requirements. Donawa ME Med Device Technol; 1997 Sep; 8(7):12-5. PubMed ID: 10174197 [TBL] [Abstract][Full Text] [Related]
9. Medical devices; device tracking. Final rule. Food and Drug Administration, HHS Fed Regist; 2002 Feb; 67(27):5943-52. PubMed ID: 11838471 [TBL] [Abstract][Full Text] [Related]
10. Medtronic v. Lohr: for want of a word, the patient was almost lost--fixing the mischief caused in Cipollone by dividing the preemption stream. Darrow Kleinhaus S Food Drug Law J; 1998; 53(2):297-320. PubMed ID: 10346686 [No Abstract] [Full Text] [Related]
11. Vioxx, radiology, and the Food and Drug Administration. Pentecost MJ J Am Coll Radiol; 2005 May; 2(5):394-7. PubMed ID: 17411841 [No Abstract] [Full Text] [Related]
12. The drug safety system conundrum. Tiedt TN Food Drug Law J; 2007; 62(3):547-558. PubMed ID: 17915396 [No Abstract] [Full Text] [Related]
13. MedWatch. On lookout for medical product problems. Ropp KL FDA Consum; 1993 Nov; 27(9):14-7. PubMed ID: 10130376 [No Abstract] [Full Text] [Related]
14. New FDA reporting rule means new concerns. Healthc Hazard Mater Manage; 1996 Mar; 9(6):1-4. PubMed ID: 10155771 [No Abstract] [Full Text] [Related]
16. The Safe Medical Devices Act. Williams MA South Hosp; 1992; 58(2):16-7. PubMed ID: 10118188 [TBL] [Abstract][Full Text] [Related]
17. Medical device reporting: the US final rule. Donawa ME Med Device Technol; 1996 Mar; 7(2):14-6, 18, 20-1. PubMed ID: 10159867 [TBL] [Abstract][Full Text] [Related]
18. Postmarket surveillance. Final rule. Food and Drug Administration, HHS Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947 [TBL] [Abstract][Full Text] [Related]
19. What you should know about FDA-USP Drug Product Problem Reporting Program. McGinnis DM Pharm Times; 1986 Apr; 52(4):101-4, 109. PubMed ID: 10276472 [No Abstract] [Full Text] [Related]
20. E-mail, snail mail, phone, or fax. Reporting adverse reactions and other product problems. Henkel J FDA Consum; 1998; 32(6):7-9. PubMed ID: 9854444 [No Abstract] [Full Text] [Related] [Next] [New Search]